Gilead Sciences Inc, Ten Percent Owner at Achillion Pharmaceuticals, holds 1.12M shares in Achillion Pharmaceuticals (Ticker: ~ACHN), holds 1.27M shares in Assembly Biosciences (Ticker: ASMB), holds 7.35M shares in Xilio Therapeutics (Ticker: XLO). Most recently, Gilead Sciences Inc ― shares of Achillion Pharmaceuticals on ― for an estimated value of ―.
What was Gilead Sciences Inc’s latest transaction?
Gilead Sciences Inc latest transaction was an Uninformative Buy of ―.
What was Gilead Sciences Inc's most profitable transaction?
Gilead Sciences Inc’s most profitable transaction was an Informative Buy of RCUS stock on January 31, 2024. The return on the trade was 17.80%.
What is Gilead Sciences Inc's role in Achillion Pharmaceuticals?
Gilead Sciences Inc's role in Achillion Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.